These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24284101

  • 21. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 22. Endogenous porphyrins in murine skin and transplanted PAM-212 squamous cell carcinoma tissues after injection of delta-aminolevulinic acid.
    Xu S, Menon IA, Becker MA, Wiltshire JD, Haberman HF, Chen Z, Gaspari AA.
    Chin Med J (Engl); 1995 Apr; 108(4):286-90. PubMed ID: 7789217
    [Abstract] [Full Text] [Related]

  • 23. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms.
    Fukuda H, Paredes S, Batlle AM.
    Drug Des Deliv; 1989 Dec; 5(2):133-9. PubMed ID: 2577983
    [Abstract] [Full Text] [Related]

  • 24. [Fluorescent diagnostics of urinary bladder cancer].
    Lopatkin NA, Kamalov AA, Kudriavtsev IuV, Tokarev FV.
    Urologiia; 2000 Dec; (4):3-6. PubMed ID: 11186690
    [Abstract] [Full Text] [Related]

  • 25. ALA induced photodynamic effects on gram positive and negative bacteria.
    Nitzan Y, Salmon-Divon M, Shporen E, Malik Z.
    Photochem Photobiol Sci; 2004 May; 3(5):430-5. PubMed ID: 15122360
    [Abstract] [Full Text] [Related]

  • 26. Current status of photodynamic technology for urothelial cancer.
    Inoue K, Fukuhara H, Yamamoto S, Karashima T, Kurabayashi A, Furihata M, Hanazaki K, Lai HW, Ogura SI.
    Cancer Sci; 2022 Feb; 113(2):392-398. PubMed ID: 34750935
    [Abstract] [Full Text] [Related]

  • 27. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
    Matveev BP, Kudashev BV, Bukharkin BV, Romanov VA, Rubanov IuV.
    Urologiia; 2000 Feb; (3):22-4. PubMed ID: 11186703
    [Abstract] [Full Text] [Related]

  • 28. Measurement of urinary porphyrins and porphyrin precursors in Dutch hospital laboratories: a review of quality control over 5 years.
    Zuijderhoudt FM, Weykamp CW, Willems HL.
    Ann Clin Biochem; 2003 Jul; 40(Pt 4):417-8. PubMed ID: 12880545
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients.
    Selmy MA, Ibrahim GH, El Serafi TI, Ghobeish AA.
    Cancer Biomark; 2010 Jul; 7(3):163-70. PubMed ID: 21263192
    [Abstract] [Full Text] [Related]

  • 30. Evaluation and clinical application of the Enterotest for the determination of human biliary porphyrin composition.
    Beukeveld GJ, Bijleveld CM, Kuipers F, Kreeftenberg HG, Huizenga JR, te Velde K, Wolthers BG.
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):453-62. PubMed ID: 7548456
    [Abstract] [Full Text] [Related]

  • 31. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
    To-Figueras J, Ozalla D, Mateu CH.
    Ann Clin Lab Sci; 2003 Jul; 33(3):251-6. PubMed ID: 12956438
    [Abstract] [Full Text] [Related]

  • 32. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
    Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, Knuechel R, Karl A, Tritschler S, Zaak D.
    Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
    [Abstract] [Full Text] [Related]

  • 33. Comparison between the fluorometric HPLC method and the conventional method for determining urinary delta-aminolevulinic acid and coproporphyrin as indices of lead exposure.
    Tomokuni K, Ichiba M, Hirai Y, Sugimoto K, Yoshida T, Hirata M.
    Int Arch Occup Environ Health; 1988 Feb; 61(3):153-6. PubMed ID: 3220586
    [Abstract] [Full Text] [Related]

  • 34. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
    Danil'chenko DI, Koenig F, Riedl K, Schnorr D, Waldman A, Al-Shukri S, Loening SA.
    Vopr Onkol; 2003 Feb; 49(6):734-7. PubMed ID: 14976918
    [Abstract] [Full Text] [Related]

  • 35. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D, Riedl C, Koenig F, Daha LK, Sachs M, Schnorr D.
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [Abstract] [Full Text] [Related]

  • 36. Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: tumor cell response to hypoxia.
    Matsumoto K, Hagiya Y, Endo Y, Nakajima M, Ishizuka M, Tanaka T, Ogura S.
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):45-51. PubMed ID: 25573285
    [Abstract] [Full Text] [Related]

  • 37. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
    Roobol MJ, Bangma CH, el Bouazzaoui S, Franken-Raab CG, Zwarthoff EC.
    Urol Oncol; 2010 Mar; 28(6):686-90. PubMed ID: 21062653
    [Abstract] [Full Text] [Related]

  • 38. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
    Huber S, Schwentner C, Taeger D, Pesch B, Nasterlack M, Leng G, Mayer T, Gawrych K, Bonberg N, Pelster M, Johnen G, Bontrup H, Wellhäusser H, Bierfreund HG, Wiens C, Bayer C, Eberle F, Scheuermann B, Kluckert M, Feil G, Brüning T, Stenzl A, UroScreen Study Group.
    BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
    [Abstract] [Full Text] [Related]

  • 39. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
    Zaak D, Frimberger D, Stepp H, Wagner S, Baumgartner R, Schneede P, Siebels M, Knüchel R, Kriegmair M, Hofstetter A.
    J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis.
    Bruce-Micah R, Hüttenberger D, Freitag L, Cullum J, Foth HJ.
    J Photochem Photobiol B; 2009 Oct 06; 97(1):1-7. PubMed ID: 19648025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.